Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Business Wire
22m
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapav…
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Reaches tentative union deal
Philip Zimbardo dies at 91
OK classroom Bible suit
Netanyahu's home targeted
Frozen waffles recalled
Fire prompts evacuations
2024 induction ceremony
Three Americans detained
PG&E shuts off power
NC breaks turnout record
Calif. oil refinery closure
US deficit reaches $1.8T
Nationwide blackout in Cuba
Emergency abortion ruling
Republicans appeal ruling
Judge unseals new evidence
At decade-high level
Bladder cancer drug pulled
G7 ministers back Ukraine
Challenges military listing
School shooting report
Antitrust ruling delayed
$4M LAPD fentanyl seizure
Ex-MN congressman dies
La Nina could arrive soon
NK sending troops to RU?
Probes near miss in Austin
Opioid suits settlement deal
Related topics
Trodelvy
United States
NASDAQ
Eli Lilly and Company
HIV
Feedback